NEW YORK (Reuters Health) – Percutaneous revascularization of the left main coronary artery can be performed via the transradial approach, with success rates similar to transfemoral access, according…
NEW YORK (Reuters Health) – In terms of efficacy and safety, low-molecular weight heparin is better than unfractionated heparin in the treatment of patients presenting with cerebral venous…
NEW YORK (Reuters Health) – Among patients undergoing left atrial radiofrequency catheter ablation for treatment of paroxysmal or persistent atrial fibrillation, the risk of symptomatic cerebral thromboembolism is…
NEW YORK (Reuters Health) – Patients with atrial fibrillation undergoing pulmonary vein isolation by radiofrequency catheter ablation are less likely to have immediate recurrence of AF if they’re…
Mark Chassin, MD, MPH, MPP, president of The Joint Commission, discusses how The Joint Commission helps hospitals eliminate complications such as catheter-related bloodstream infections and surgical site infections.…
Mark R. Chassin, MD, MPH, MPP, president of The Joint Commission, discusses Improving America’s Hospitals, the organization’s 2010 annual report on quality and safety. The Joint Commission compiles…
NEW YORK (Reuters Health) – Results of a meta-analysis indicate that anticoagulation may not need to be interrupted in patients undergoing elective coronary angiography. However, the quality of…
NEW YORK (Reuters Health) – For octogenarians undergoing percutaneous coronary intervention, the use of drug-eluting stents is safe and more effective than using bare metal stents, a Dutch…
NEW YORK (Reuters Health) – The GLP-1 receptor agonist exenatide used to treat type 2 diabetes is associated with a lower risk of cardiovascular disease (CVD) events, compared…
NEW YORK (Reuters Health) – For patients with significant carotid artery stenosis, undergoing carotid artery stenting (CAS) carries a higher risk of death or stroke than does carotid…